Pseudonymization of patient identifiers for translational research

The usage of patient data for research poses risks concerning the patients’ privacy and informational self-determination. Next-generation-sequencing technologies and various other methods gain data from biospecimen, both for translational research and personalized medicine. If these biospecimen are...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Aamot, Harald Andreas (Autore) , Kohl, Christian Dominik (Autore) , Richter, Daniela (Autore) , Knaup-Gregori, Petra (Autore)
Natura: Article (Journal)
Lingua:inglese
Pubblicazione: 24 July 2013
In: BMC medical informatics and decision making
Year: 2013, Volume: 13, Pages: 1-15
ISSN:1472-6947
DOI:10.1186/1472-6947-13-75
Accesso online:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/1472-6947-13-75
Testo
Note sull'autore:Harald Aamot, Christian Dominik Kohl, Daniela Richter and Petra Knaup-Gregori
Descrizione
Riassunto:The usage of patient data for research poses risks concerning the patients’ privacy and informational self-determination. Next-generation-sequencing technologies and various other methods gain data from biospecimen, both for translational research and personalized medicine. If these biospecimen are anonymized, individual research results from genomic research, which should be offered to patients in a clinically relevant timeframe, cannot be associated back to the individual. This raises an ethical concern and challenges the legitimacy of anonymized patient samples. In this paper we present a new approach which supports both data privacy and the possibility to give feedback to patients about their individual research results.
Descrizione del documento:Gesehen am 04.05.2021
Descrizione fisica:Online Resource
ISSN:1472-6947
DOI:10.1186/1472-6947-13-75